Written by Klarity Editorial Team
Published: Jul 5, 2026

Last updated: July 5, 2026
If you have Anthem Blue Cross Blue Shield coverage in Connecticut and are exploring options for online weight loss treatment, understanding how your plan may handle weight management services and medications is an important first step. Coverage for GLP-1 receptor agonists, anti-obesity medications, and comprehensive weight management programs varies significantly by plan type, employer benefit design, and formulary tier. This guide explains how Anthem BCBS plans in Connecticut may approach weight loss coverage, what prior authorization requirements to expect, and what steps you can take to verify your benefits before booking an appointment.
Check if your Anthem Blue Cross Blue Shield plan may cover weight loss treatment in Connecticut →
See if you may qualify for online weight loss treatment at Klarity Health
Anthem Blue Cross Blue Shield offers several plan types in Connecticut, including individual and family plans through the Access Health CT state exchange, employer-sponsored group plans (fully insured and self-funded/ERISA), and Medicare Advantage plans. Whether weight loss treatment and anti-obesity medications are covered depends on your specific plan’s benefit design and formulary.
Under the Affordable Care Act, non-grandfathered individual and small-group plans sold in Connecticut must cover certain preventive services, which may include obesity screening and counseling. However, coverage for prescription weight loss medications and structured weight management programs goes beyond the preventive services floor and varies substantially by plan.
Connecticut’s mental health parity law, CGS § 38a-514b, requires that mental health and substance use disorder benefits be provided at parity with medical and surgical benefits. While this statute does not directly mandate weight loss coverage, it is relevant for patients whose obesity is accompanied by behavioral health comorbidities such as binge eating disorder, depression related to weight, or anxiety. Plans that cover these behavioral health conditions must provide that coverage at parity with medical benefits — which may affect how integrated care is structured for patients managing both mental health and weight.
Connecticut’s telehealth parity statute requires Anthem BCBS fully insured plans to cover telehealth services at parity with in-person care for covered benefits. If your plan covers weight loss consultations or medication management in person, that coverage must generally extend to telehealth visits as well.
ERISA note: Self-funded employer plans are governed by federal ERISA, which means Connecticut state insurance mandates — including CGS § 38a-514b and telehealth parity — may not apply to these plans. If your coverage comes through an employer’s self-funded plan, your benefits are determined by the plan document, not Connecticut state law. Contact your HR department or plan administrator to confirm which rules govern your coverage.
Coverage for GLP-1 receptor agonists and other anti-obesity medications varies across Anthem BCBS plans in Connecticut. The following reflects typical formulary placement patterns based on publicly available formulary information, but your specific plan may differ. Always verify with Anthem BCBS member services before assuming any medication is covered.
Wegovy is FDA-approved specifically for chronic weight management and is distinct from Ozempic, which contains the same active ingredient but is approved for type 2 diabetes. On most Anthem BCBS plans, Wegovy is placed at Tier 3 or Tier 4 and typically requires prior authorization. PA criteria generally include a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or sleep apnea. Some plans also require documentation of prior attempts at lifestyle modification. Step therapy requiring a lower-cost agent first may apply on certain Anthem plan designs before Wegovy is approved.
Zepbound is FDA-approved for chronic weight management and is distinct from Mounjaro (same active ingredient, diabetes indication). Coverage for Zepbound on Anthem BCBS plans in Connecticut is plan-specific. Some plans cover it at Tier 3-4 with prior authorization; others may exclude it or require step therapy through Wegovy or another agent first. Check your plan’s Summary of Benefits and Coverage (SBC) or call member services to confirm whether Zepbound appears on your formulary for the current plan year.
Ozempic (semaglutide, diabetes) and Mounjaro (tirzepatide, diabetes) are approved for type 2 diabetes management, not for weight loss. Most Anthem BCBS plans in Connecticut will not approve Ozempic or Mounjaro for a primary weight loss diagnosis. Prescribing these medications solely for weight loss without a diabetes diagnosis may result in a coverage denial. Patients who have both type 2 diabetes and excess weight should work with their provider to document the diabetes indication clearly in order to support a coverage request.
Saxenda is FDA-approved for chronic weight management and is typically placed at Tier 3 on Anthem BCBS formularies, with step therapy and prior authorization required. Some plans require patients to try phentermine or another lower-tier agent before Saxenda is approved. Daily subcutaneous injection administration is a practical consideration for patients evaluating this option versus weekly GLP-1 alternatives.
Phentermine is typically placed at Tier 1-2 on Anthem BCBS formularies in Connecticut with no prior authorization required on most plans, making it one of the most accessible weight loss medications from a coverage and cost perspective. As a Schedule IV controlled substance, phentermine is subject to a 30-day supply limit per fill. It is generally approved for short-term use (up to 12 weeks), and some plans require BMI and comorbidity documentation before approving refills beyond the initial prescription.
Qsymia is a combination medication (phentermine + extended-release topiramate) FDA-approved for chronic weight management. It is placed at Tier 3-4 on most Anthem BCBS formularies and requires prior authorization with step therapy. As a Schedule IV controlled substance, it is subject to a 30-day supply limit. PA criteria typically mirror Wegovy (BMI ≥30 or ≥27 + comorbidity) and usually require documentation of prior lifestyle modification attempts.
Contrave is a non-controlled combination medication (naltrexone + extended-release bupropion) approved for chronic weight management. It is typically placed at Tier 3-4 on Anthem BCBS plans with prior authorization and step therapy required. Patients who are already taking bupropion for depression or who have a history of seizures should discuss contraindications with their provider before pursuing Contrave.
Prescription orlistat (Xenical) is typically placed at a low tier on Anthem BCBS formularies and generally does not require prior authorization. Over-the-counter Alli (half-dose orlistat) is not covered as a prescription benefit but is available without a prescription at a lower out-of-pocket cost.
Check if your Anthem Blue Cross Blue Shield plan may cover weight loss treatment in Connecticut →
See if you may qualify for online weight loss treatment at Klarity Health
The type of Anthem BCBS plan you have affects which weight loss coverage rules apply:
Most Anthem BCBS weight loss medications at Tier 3-4 require prior authorization before the pharmacy will dispense them. Here is what to expect:
For questions about your PA status or to escalate a denial, contact Anthem BCBS member services at the number on your insurance card. If you believe a denial is improper, you may also file a complaint with the Connecticut Insurance Department (CID) at 1-800-203-3447 or visit portal.ct.gov/cid.
Anthem Blue Cross Blue Shield offers LiveHealth Online as its branded telehealth platform for Anthem members. LiveHealth Online is a separate service from Klarity Health. Klarity Health operates independently and is not affiliated with LiveHealth Online or Anthem Blue Cross Blue Shield. When you use Klarity Health, you are using an independent telehealth platform. Whether your Klarity Health visits are covered depends on your specific Anthem plan’s telehealth benefits and out-of-network policies. Verify your telehealth and weight loss benefits with Anthem BCBS before booking an appointment.
Wegovy may be covered on some Anthem BCBS plans in Connecticut, typically at Tier 3-4 with prior authorization. Coverage is not guaranteed and depends on your specific plan’s formulary and benefit design. PA criteria generally include BMI ≥30 or BMI ≥27 with a qualifying comorbidity. Verify with Anthem BCBS member services before booking or filling a prescription.
Ozempic is approved for type 2 diabetes, not for weight loss. Most Anthem BCBS plans in Connecticut will not cover Ozempic solely for a weight loss diagnosis. Wegovy or Zepbound are the appropriate GLP-1 medications for a weight loss indication. If you have type 2 diabetes and excess weight, coverage may be available under the diabetes indication — work with your provider to document the appropriate indication.
Step therapy may be required on some Anthem BCBS plans before approving Wegovy or Saxenda. Step therapy typically requires trying a lower-cost agent (such as phentermine) first and documenting insufficient response before higher-tier GLP-1s are approved. Your provider can document the clinical rationale for bypassing step therapy in situations where lower-tier options are medically contraindicated.
CGS § 38a-514b is Connecticut’s mental health and substance use disorder parity law. It does not directly mandate weight loss coverage. However, it may be relevant when obesity is accompanied by a behavioral health comorbidity such as binge eating disorder, depression, or anxiety. Plans must cover these behavioral health conditions at parity with medical and surgical benefits. Self-funded ERISA plans are generally not bound by this Connecticut state law.
If Anthem BCBS denies a PA request for a weight loss medication, request a written denial that includes the specific reason. File an internal appeal with Anthem BCBS using the process described in your denial letter. If the internal appeal is denied, you may request an independent external review. For assistance, contact the Connecticut Insurance Department at 1-800-203-3447.
Connecticut’s telehealth parity statute requires Anthem BCBS fully insured plans to cover telehealth services at parity with in-person care for covered benefits. If your plan covers in-person weight loss consultations or medication management, that coverage must generally extend to telehealth. Self-funded ERISA plans are not subject to this Connecticut state requirement.
Coverage for weight loss treatment, GLP-1 medications, and related services varies by individual plan, employer benefit design, and formulary year. Nothing in this guide constitutes a guarantee of coverage. Always verify your specific benefits with Anthem Blue Cross Blue Shield member services before booking an appointment or filling a prescription. Klarity Health is not affiliated with Anthem Blue Cross Blue Shield or LiveHealth Online.
Check if your Anthem Blue Cross Blue Shield plan may cover weight loss treatment in Connecticut →
See if you may qualify for online weight loss treatment at Klarity Health
See if you may qualify for online weight loss treatment at Klarity Health →
Find the right provider for your needs — select your state to find expert care near you.